These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3895799)

  • 1. Effects of luteinizing hormone-releasing hormone (LRH) upon bioactive and immunoreactive serum LH in patients with Turner's syndrome before and after oestrogen treatment.
    Celani MF; Montanini V; Marrama P
    Acta Endocrinol (Copenh); 1985 Jul; 109(3):304-8. PubMed ID: 3895799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of acute stimulation with luteinizing hormone-releasing hormone (LRH) on biologically active and immunoreactive serum luteinizing hormone (LH) in pubertal boys.
    Montanini V; Celani MF; Baraghini GF; Carani C; Marrama P
    Acta Endocrinol (Copenh); 1984 Nov; 107(3):289-94. PubMed ID: 6391056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LRH-stimulated release of bioactive and immunoreactive LH in a patient with the XX male syndrome.
    Grandi M; Borghi A; Vaccari F; Celani MF
    Exp Clin Endocrinol; 1987 Apr; 89(2):229-32. PubMed ID: 3301372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of acute stimulation with gonadotropin releasing hormone (GnRH) on biologically active serum luteinizing hormone (LH) in elderly men.
    Celani MF; Montanini V; Baraghini GF; Carani C; Marrama P
    J Endocrinol Invest; 1984 Dec; 7(6):589-95. PubMed ID: 6397502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The changing ratio of bioactive to immunoreactive luteinizing hormone (LH) through puberty principally reflects changing LH radioimmunoassay dose-response characteristics.
    Burstein S; Schaff-Blass E; Blass J; Rosenfield RL
    J Clin Endocrinol Metab; 1985 Sep; 61(3):508-13. PubMed ID: 3894406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific, time-dependent actions of low-dose ethinyl estradiol administration on the episodic release of growth hormone, follicle-stimulating hormone, and luteinizing hormone in prepubertal girls with Turner's syndrome.
    Mauras N; Rogol AD; Veldhuis JD
    J Clin Endocrinol Metab; 1989 Nov; 69(5):1053-8. PubMed ID: 2507569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Luteinizing hormone and follicle-stimulating hormone secretory dynamics in Turner's syndrome.
    Boyar RM; Ramsey J; Chipman J; Fevre M; Madden J; Marks JF
    J Clin Endocrinol Metab; 1978 Nov; 47(5):1078-83. PubMed ID: 122419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decrease in luteinizing hormone biological activity/immunoreactivity ratio in elderly men.
    Marrama P; Montanini V; Celani MF; Carani C; Cioni K; Bazzani M; Cavani D; Baraghini GF
    Maturitas; 1984 Apr; 5(4):223-31. PubMed ID: 6738369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of oestrogen treatment on serum gonadotrophin bioactivity, immunoreactivity and isohormone distribution, and on immunoreactive inhibin levels, in prostatic cancer patients.
    Matikainen T; Haavisto AM; Permi J; de Kretser D; Huhtaniemi I
    Clin Endocrinol (Oxf); 1994 Jun; 40(6):743-50. PubMed ID: 8033364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologically active luteinizing hormone (LH) in Klinefelter's syndrome: response to gonadotropin-releasing hormone (GnRH) and effects of testosterone undecanoate.
    Montanini V; Celani MF; Carani C; Cioni K; Simoni M; Baraghini GF; Marrama P
    Andrologia; 1987; 19(1):58-65. PubMed ID: 3318557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ratios of serum bioactive/immunoreactive luteinizing hormone and follicle-stimulating hormone in various clinical conditions with increased and decreased gonadotropin secretion: reevaluation by a highly sensitive immunometric assay.
    Jaakkola T; Ding YQ; Kellokumpu-Lehtinen P; Valavaara R; Martikainen H; Tapanainen J; Rönnberg L; Huhtaniemi I
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1496-505. PubMed ID: 2140831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oestrogens induce an LH surge in a prepubertal patient with 45,X gonadal dysgenesis under prolonged pulsatile LRH administration.
    Delemarre-van de Waal HA; Van den Brande JL; van Kessel H; Schoemaker J
    Acta Endocrinol (Copenh); 1983 Feb; 102(2):185-9. PubMed ID: 6402864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the bioactivity to immunoreactivity ratio of circulating luteinizing hormone in impotent men treated with testosterone undecanoate.
    Carani C; Celani MF; Zini D; Baldini A; Della Casa L; Marrama P
    Acta Endocrinol (Copenh); 1989 Mar; 120(3):284-8. PubMed ID: 2648724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of the potency of luteinizing hormone by estrogen.
    Lucky AW; Rebar RW; Rosenfield RL; Roche-Bender N; Helke J
    N Engl J Med; 1979 May; 300(18):1034-6. PubMed ID: 431597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of LH/FSH releasing hormone (LRH) on the basal secretion of gonadotrophins in relation to plasma levels of oestradiol, progesterone and prolactin during the post-partum period in lactating and in non-lactating women.
    Jeppsson S; Rannevik G; Thorell JI; Wide L
    Acta Endocrinol (Copenh); 1977 Apr; 84(4):713-28. PubMed ID: 322431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged pulsatile administration of luteinizing hormone-releasing hormone in prepubertal children: diagnostic and physiologic aspects.
    Delemarre-van de Waal HA; Van den Brande JL; Schoemaker J
    J Clin Endocrinol Metab; 1985 Nov; 61(5):859-67. PubMed ID: 3930552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroidal regulation of biologically active luteinizing hormone secretion in men and women.
    Veldhuis JD; Dufau ML
    Hum Reprod; 1993 Nov; 8 Suppl 2():84-96. PubMed ID: 8276976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro bioassay of LH in human serum: the rat interstitial cell testosterone (RICT) assay.
    Dufau ML; Pock R; Neubauer A; Catt KJ
    J Clin Endocrinol Metab; 1976 May; 42(5):958-69. PubMed ID: 1270585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of luteinizing hormone releasing hormone (LHRH) upon bioactive and immunoreactive serum LH levels in normal subjects.
    Dufau ML; Beitins IZ; McArthur JW; Catt KJ
    J Clin Endocrinol Metab; 1976 Sep; 43(3):658-67. PubMed ID: 783183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease.
    Fauser BC; Pache TD; Lamberts SW; Hop WC; de Jong FH; Dahl KD
    J Clin Endocrinol Metab; 1991 Oct; 73(4):811-7. PubMed ID: 1909705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.